Kaempferol inhibits vascular smooth muscle cell migration by modulating BMP-mediated miR-21 expression

Molecular and Cellular Biochemistry

Volumn 407, Issue 1-2, 2015, Pages 143-149

  Kim, Kwangho ^a   Kim, Sunghwan ^b   Moh, Sang Hyun ^c   Kang, Hara ^a  

^a SolarLight Ltd   (South Korea)

^b Daegu Gyeongbuk Medical Innovation Foundation   (South Korea)

^c Antiaging Research Institute of BIO FD C Co Ltd   (South Korea)

Author keywords

BMP; Cell migration; Kaempferol; microRNA 21; Vascular smooth muscle cells

Indexed keywords

BONE MORPHOGENETIC PROTEIN 4; KAEMPFEROL; LUCIFERASE; MICRORNA 21; PLATELET DERIVED GROWTH FACTOR; BMP4 PROTEIN, HUMAN; KAEMPFEROL DERIVATIVE; MICRORNA; MIRN21 MICRORNA, HUMAN;

ARTICLE; CARDIOVASCULAR DISEASE; CELL MIGRATION; CONTROLLED STUDY; DRUG MECHANISM; ENZYME ACTIVITY; GENE EXPRESSION; HUMAN; HUMAN CELL; IN VITRO STUDY; MODULATION; PULMONARY ARTERY SMOOTH MUSCLE CELL; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; VASCULAR SMOOTH MUSCLE CELL; CELL CULTURE; CELL MOTION; CELL PROLIFERATION; CYTOLOGY; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PHYSIOLOGY; VASCULAR SMOOTH MUSCLE;

BONE MORPHOGENETIC PROTEIN 4; CELL MOVEMENT; CELL PROLIFERATION; CELLS, CULTURED; GENE EXPRESSION REGULATION; HUMANS; KAEMPFEROLS; MICRORNAS; MUSCLE, SMOOTH, VASCULAR; SIGNAL TRANSDUCTION;

EID: 84939267613     PISSN: 03008177     EISSN: 15734919     Source Type: Journal    
DOI: 10.1007/s11010-015-2464-5     Document Type: Article

References (23)

1. Hertog MG, Feskens EJ, Kromhout D (1997) Antioxidant flavonols and coronary heart disease risk. Lancet 349:699. doi:10.1016/S0140-6736(05)60135-3
2. Calderon-Montano JM, Burgos-Moron E, Perez-Guerrero C, Lopez-Lazaro M (2011) A review on the dietary flavonoid kaempferol. Mini Rev Med Chem 11:298–344
3. Wu WB, Hung DK, Chang FW, Ong ET, Chen BH (2012) Anti-inflammatory and anti-angiogenic effects of flavonoids isolated from Lycium barbarum Linnaeus on human umbilical vein endothelial cells. Food Funct 3:1068–1081. doi:10.1039/c2fo30051f
4. Ross R (1999) Atherosclerosis: an inflammatory disease. N Engl J Med 340:115–126. doi:10.1056/NEJM199901143400207
5. Kong L, Luo C, Li X, Zhou Y, He H (2013) The anti-inflammatory effect of kaempferol on early atherosclerosis in high cholesterol fed rabbits. Lipids Health Dis 12:115. doi:10.1186/1476-511X-12-115
6. Chen SS, Michael A, Butler-Manuel SA (2012) Advances in the treatment of ovarian cancer: a potential role of antiinflammatory phytochemicals. Discov Med 13:7–17
7. Kim SY, Jin YR, Lim Y, Kim JH, Cho MR, Hong JT, Yoo HS, Yun YP (2005) Inhibition of PDGF beta-receptor tyrosine phosphorylation and its downstream intracellular signal transduction in rat aortic vascular smooth muscle cells by kaempferol. Planta Med 71:599–603. doi:10.1055/s-2005-871263
8. Nepal M, Li L, Cho HK, Park JK, Soh Y (2013) Kaempferol induces chondrogenesis in ATDC5 cells through activation of ERK/BMP-2 signaling pathway. Food Chem Toxicol 62:238–245. doi:10.1016/j.fct.2013.08.034
9. Owens GK, Kumar MS, Wamhoff BR (2004) Molecular regulation of vascular smooth muscle cell differentiation in development and disease. Physiol Rev 84:767–801. doi:10.1152/physrev.00041.2003
10. ten Dijke P, Arthur HM (2007) Extracellular control of TGFbeta signalling in vascular development and disease. Nat Rev Mol Cell Biol 8:857–869
11. Chan MC, Hilyard AC, Wu C, Davis BN, Hill NS, Lal A, Lieberman J, Lagna G, Hata A (2010) Molecular basis for antagonism between PDGF and the TGFbeta family of signalling pathways by control of miR-24 expression. EMBO J 29:559–573. doi:10.1038/emboj.2009.370
12. Kang H, Hata A (2012) MicroRNA regulation of smooth muscle gene expression and phenotype. Curr Opin Hematol 19:224–231
13. Kang H, Davis-Dusenbery BN, Nguyen PH, Lal A, Lieberman J, Van Aelst L, Lagna G, Hata A (2011) Bone morphogenetic protein 4 promotes vascular smooth muscle contractility by activating microRNA-21 (miR-21), which down-regulates expression of family of dedicator of cytokinesis (DOCK) proteins. J Biol Chem 287:3976–3986
14. Kang H, Louie J, Weisman A, Sheu-Gruttadauria J, Davis-Dusenbery BN, Lagna G, Hata A (2012) Inhibition of MicroRNA-302 (miR-302) by bone morphogenetic protein 4 (BMP4) facilitates the BMP signaling pathway. J Biol Chem 287:38656–38664
15. Kim S, Hata A, Kang H (2014) Down-regulation of miR-96 by bone morphogenetic protein signaling is critical for vascular smooth muscle cell phenotype modulation. J Cell Biochem 115:889–895. doi:10.1002/jcb.24730
16. Kim S, Kang H (2013) miR-15b induced by platelet-derived growth factor signaling is required for vascular smooth muscle cell proliferation. BMB Rep 46:550–554
17. Davis BN, Hilyard AC, Lagna G, Hata A (2008) SMAD proteins control DROSHA-mediated microRNA maturation. Nature 454:56–61
18. Dubey RK, Gillespie DG, Imthurn B, Rosselli M, Jackson EK, Keller PJ (1999) Phytoestrogens inhibit growth and MAP kinase activity in human aortic smooth muscle cells. Hypertension 33:177–182
19. Yu PB, Deng DY, Lai CS, Hong CC, Cuny GD, Bouxsein ML, Hong DW, McManus PM, Katagiri T, Sachidanandan C, Kamiya N, Fukuda T, Mishina Y, Peterson RT, Bloch KD (2008) BMP type I receptor inhibition reduces heterotopic [corrected] ossification. Nat Med 14:1363–1369. doi:10.1038/nm.1888
20. Corella D, Ordovas JM (2014) How does the Mediterranean diet promote cardiovascular health? Current progress toward molecular mechanisms: gene-diet interactions at the genomic, transcriptomic, and epigenomic levels provide novel insights into new mechanisms. BioEssays 36:526–537. doi:10.1002/bies.201300180
21. Owens GK (1995) Regulation of differentiation of vascular smooth muscle cells. Physiol Rev 75:487–517
22. Altamemi I, Murphy EA, Catroppo JF, Zumbrun EE, Zhang J, McClellan JL, Singh UP, Nagarkatti PS, Nagarkatti M (2014) Role of microRNAs in resveratrol-mediated mitigation of colitis-associated tumorigenesis in Apc(Min/+) mice. J Pharmacol Exp Ther 350:99–109. doi:10.1124/jpet.114.213306
23. Davalos A, Fernandez-Hernando C (2013) From evolution to revolution: miRNAs as pharmacological targets for modulating cholesterol efflux and reverse cholesterol transport. Pharmacol Res 75:60–72. doi:10.1016/j.phrs.2013.02.005